Gastroesophageal Reflux Clinical Trial
Official title:
The Effect of Position on Oesophageal Peristalsis and LOS Pressures: a High Resolution Manometry Study
High Resolution Manometry (HRM) is a new advance in oesophageal measurement that permits the
acquisition of pressure data through the entire length of the oesophagus over time via
closely spaced sensors that continuously record the motor activity of the oesophagus. This
allows not only contractile pressure to be measured, but also the coordination
(proximal-distal) of contractions and the development of effective intra-bolus pressure (the
force that drives bolus movement).
The study hypothesis is that (1) there will be a progressive increase in peristaltic
pressure and decrease in velocity as the subjects move from the upright, through the supine
to the upside down position and (2) the increase in pressure will be most evident in the
mid-oesophagus at the transition zone between the striated and the smooth muscle
contractions.
| Status | Completed |
| Enrollment | 25 |
| Est. completion date | August 2010 |
| Est. primary completion date | August 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years to 70 Years |
| Eligibility |
Inclusion criteria Subjects to be included in the study are those: 1. male or female 2. at least 18 years of age 3. have given informed consent for the HRM procedure Exclusion Criteria For normal controls: 1. with symptoms or a history of oesophageal gastrointestinal disease 2. with regular intake of medication. Occasional use of analgesic (e.g. aspirin) is allowed 3. with any hematological abnormalities 4. with any evidence of infectious disease 5. who are pregnant or breast-feeding. 6. with evidence or history of drug or alcohol abuse within the past two years 7. with diabetes mellitis 8. with mental impairment limiting the ability to comply with study requirements 9. who are taking or planning to take other investigational drugs during the study 10. with use of medications influencing upper GI motility within one week of the study (i.e. calcium channel blockers, prokinetic drugs, macrolide antibiotics). 11. with use of PPIs and H2 blockers For patients: 1. with no oesophageal symptoms (e.g. referred for studies prior to bariatric surgery) 2. with mental impairment limiting the ability to comply with study requirements 3. who are taking or planning to take other investigational drugs during the study 4. with use of medications influencing upper GI motility within one week of the study (i.e. calcium channel blockers, prokinetic drugs, macrolide antibiotics). |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Oesophageal Laboratory, GSTT | London |
| Lead Sponsor | Collaborator |
|---|---|
| Guy's and St Thomas' NHS Foundation Trust |
United Kingdom,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05561179 -
Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease
|
N/A | |
| Withdrawn |
NCT02213887 -
Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
|
Phase 4 | |
| Completed |
NCT01946971 -
Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01825473 -
Study of Erythromycin in GER-Associated Apnea of the Newborn
|
N/A | |
| Completed |
NCT00614536 -
Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period
|
Phase 4 | |
| Completed |
NCT00284908 -
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00365300 -
Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)
|
Phase 3 | |
| Completed |
NCT00373997 -
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
|
Phase 4 | |
| Completed |
NCT00291746 -
Validation of RDQ Questionnaire
|
Phase 4 | |
| Completed |
NCT00215787 -
Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease
|
N/A | |
| Completed |
NCT00226044 -
Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.
|
Phase 3 | |
| Completed |
NCT01167543 -
Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease
|
N/A | |
| Completed |
NCT00567021 -
German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms
|
N/A | |
| Completed |
NCT00141960 -
Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease
|
Phase 2/Phase 3 | |
| Completed |
NCT01048840 -
Natural History of Gastroesophageal Reflux (GER) in Children < 12 Years of Age
|
||
| Completed |
NCT00181805 -
Natural History of Gastroesophageal Reflux (GER) in Children and Adolescents
|
||
| Terminated |
NCT01281553 -
A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease
|
Phase 4 | |
| Completed |
NCT05486169 -
Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy
|
N/A | |
| Completed |
NCT04034017 -
Gastroesophageal Reflux Disease Among College Students
|
||
| Terminated |
NCT03226054 -
Determining Risk Factors for Successful PPI Weaning
|
N/A |